RayzeBio inc (DELISTED) (RYZB:DL)
62.49
0.00 (0.00%)
USD |
NASDAQ |
Mar 06, 16:00
RayzeBio Total Assets (Quarterly): 603.51M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 603.51M |
| June 30, 2023 | 305.76M |
| Date | Value |
|---|---|
| December 31, 2022 | 324.78M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
305.76M
Minimum
Jun 2023
603.51M
Maximum
Sep 2023
411.35M
Average
324.78M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 93.67B |
| Karuna Therapeutics Inc (DELISTED) | 1.336B |
| Ambrx Biopharma Inc (DELISTED) | 271.50M |
| Pfizer Inc | 219.48B |
| Mirati Therapeutics Inc (DELISTED) | 1.130B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 28.19M |
| Shareholders Equity (Quarterly) | 575.32M |